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Case report
A 56 year old man with a history of smok-
ing related COPD was admitted to our hos-
pital with a one week history of worsening
chronic cough with the recent development
of haemorrhagic phlegm and a subfebrile
state. Chest x-rays showed a cavitary infiltrate
in the left upper lobe, a right pleural effusion
and bilateral mediastinal partially calcified
enlarged lymph nodes. Direct sputum exam-
ination was positive for M. tuberculosis and
was confirmed by culture. Eight days after ini-
tiation of a standard four drug antituberculo-
sis treatment regime the patient presented
with repeated and major haemoptysis of up to
200 ml/event. Chest x-ray showed a new air
fluid level in the left superior cavity. A CT-
scan of the thorax disclosed a voluminous Ras-
mussen’s pseudoaneurysm (figure 1). Selec-
tive catheterization using a femoral approach
to the left apical superior pulmonary artery
showed the pseudoaneurysm arising from a
subsegmental branch (figure 2). The branch
was selectively embolized with 3 coils (0.035
inches 5–3 mm in diameter [COOK, Bloom-
ington, Indiana, USA]) resulting in occlusion
of this segmental branch and no filling of 
the pseudoaneurysm (figure 2). Haemoptysis
stopped and over the next few days sputum
became negative for acid fast bacilli. No
further surgical intervention was performed.
Chest x-ray after one year follow-up showed
resolution of the cavitary lesion and no recur-
rence of haemoptysis. Standardized tubercu-
losis treatment with a four drug regime (iso-
niazid – rifampicin – pyrazinamide – etham-
butol) over two months followed by four
months of a two drug regime (isoniazid – ri-
fampicin) was successfully completed and the
patient was declared cured at the end of the
treatment (1 direct exam and 2 negative
cultures before the end of the treatment) [1].
Discussion
Numerous sequelae and complications
occuring in pulmonary tuberculosis can give
rise to haemoptysis [2]: parenchymal lesions
(aspergilloma invading an open healed cavity,
scar carcinoma), airway lesions (bronchiecta-
sis, broncholithiasis) or vascular lesions (pul-
monary or bronchial arteritis and thrombosis
or dilatation). Up to one third of patients with
pulmonary tuberculosis will develop haemop-
tysis during the course of their illness [3] and
before the advent of antibiotic therapy mas-
sive haemoptysis was the cause of 4–7% of
deaths [4]. In the United States tuberculosis
is responsible for 7 to 16 percent of all cases
of haemoptysis [4]. In approximately 80% of
cases the hemorrhagic source is found in the
bronchial or other systemic arteries supplying
the lung and in the remaining 20% in the 
pulmonary arteries [5]. Most bleeds are
caused by vascular erosion without develop-
ment of a pseudoaneurysm. In 1868, in a 
series of autopsies performed on tuberculous
patients with a fatal haemoptysis, Rasmussen
described nine cases of ruptured aneurysmal
vessels originating from branches of the
pulmonary artery in a tangential position to
the cavity wall [6]. Systematic autopsies 
performed on patients who died with cavitary
lesions has shown the presence of a pseudo-
aneurysm of Rasmussen in four percent of
cases [7]. Inflammatory response and destruc-
tion due to the spread of tuberculosis into 
the adventitia and media of pulmonary or
bronchial artery walls results in the weaken-
ing of the arterial wall, allowing the develop-
ment of a herniation of the vessel into the
lumen of the cavity (pseudoaneurysm). The
risk of rupture is then high due to the devel-
opment of the aneurysm and the inflamma-
tory processes in the arterial wall.
The indication for radiological or surgi-
cal intervention is considered when major
(>200 ml per 24 hours) haemoptysis occurs.
No randomised study has compared the re-
sults of interventional radiology with surgical
resection. Surgical resection of the bleeding
site (usually lobectomy) allows a definitive re-
covery when the patient is operable [4]. Alter-
natively, bronchial or pulmonary emboliza-
tion is considered first-line treatment in the
case of massive haemoptysis or when a patient
is not a candidate for surgery, either as a tem-
porary measure before surgery or as a defini-
tive therapy [8]. Contrast-enhanced CT-scan
is the cornerstone procedure to localize
haemoptysis and also to detect any obvious
vascular anomalies such as Rasmussen’s
pseudoaneurysm. If systemic and pulmonary
angiographies fail to supply the diagnosis,
bronchial or other systemic arteries supplying
the lung may be electively embolized either
on the side of bleeding or in their totality.
Selective angiographic embolization of the
supplying pulmonary arteries may also be
performed when the haemorrhagic source is
obviously from the pulmonary circulation
(Rasmussen’s pseudoaneurysm), or in the case
of recurrent bleeding after embolization of
the systemic circulation, having excluded a
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Figure 2 
On the left side, selective catheterization of the apical left superior pulmonary artery demonstrates
a voluminous pseudoaneurysm deriving from a subsegmental branch. On the right side, angiogra-
phy shows complete occlusion of the involved branch and no filling of the pseudoaneurysm after
the embolization with coils.
Figure 1 
CT Scan shows enhancement by contrast of a
voluminous Rasmussen’s pseudoaneurysm 
of the left superior cavity wall.
recurrence in the territory already treated.
While conservative pulmonary transcatheter
occlusion is generally a safe procedure, a small
number of major complications cannot be
avoided, as for example, the rupture of an
aneurysm or of fragile vessels caused by in-
creased pressure during hyperselective injec-
tion [9]. These complications cannot always
be managed conservatively so that the avail-
ability of a thoracic surgeon on site is neces-
sary during the procedure [10].
Conclusion
Rasmussen’s aneurysm is a rare condition
that may lead to life threatening haemoptysis
during the course of pulmonary tuberculosis.
Selective angiographic embolization of arter-
ies supplying the aneurysm is a safe alterna-
tive to surgery for stopping the haemorrhage
with minimal risk.
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